Literature DB >> 22201827

Cross-reactivity of autoreactive T cells with MBP and viral antigens in patients with MS.

Weizhi Cheng1, Yanhui Ma, Fang Gong, Chaoying Hu, Liu Qian, Qiuyu Huang, Qiwen Yu, Jiying Zhang, Shengdi Chen, Zhengguo Liu, Xuehua Chen, Tong Zhou, Dongqing Zhang.   

Abstract

In this study, we detected the viral DNA of Human Herpes Virus 6 (HHV-6) in the sera and cell-free cerebrospinal fluid (CSF) of Chinese multiple sclerosis (MS) patients. The results revealed that the copy numbers of serum HHV-6 viral DNA were higher in MS than in normal subjects (NS) or in other neurologic diseases (OND). We also found that in the MS subjects, most T cells recognizing myelin basic protein (MBP) were cross-reactive and could be activated by a synthetic peptide corresponding to residues of HHV-6 or EBV. The estimated precursor frequency of these cross-reactive T cells recognizing both peptides, MBP and HHV-6 or EBV, was significantly elevated in MS compared with that in controls. More significant was the presence of CD8+ cytotoxic cross-reactive T cells, as they could directly induce injury to oligodendrocytes that are known to express both MBP and MHC class I molecules. The study provides important evidence for understanding the potential role of HHV-6 or EBV infection in the pathogenesis of MS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22201827     DOI: 10.2741/4010

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  14 in total

1.  p53-Pirh2 Complex Promotes Twist1 Degradation and Inhibits EMT.

Authors:  Yang Yang-Hartwich; Roslyn Tedja; Cai M Roberts; Jamie Goodner-Bingham; Carlos Cardenas; Marta Gurea; Natalia J Sumi; Ayesha B Alvero; Carlotta A Glackin; Gil Mor
Journal:  Mol Cancer Res       Date:  2018-08-21       Impact factor: 5.852

Review 2.  CD8(+) T cells in multiple sclerosis.

Authors:  Aleksandar Denic; Bharath Wootla; Moses Rodriguez
Journal:  Expert Opin Ther Targets       Date:  2013-07-06       Impact factor: 6.902

Review 3.  Immune response to HHV-6 and implications for immunotherapy.

Authors:  Aniuska Becerra; Laura Gibson; Lawrence J Stern; J Mauricio Calvo-Calle
Journal:  Curr Opin Virol       Date:  2014-10-27       Impact factor: 7.090

Review 4.  Evidence linking HHV-6 with multiple sclerosis: an update.

Authors:  Emily C Leibovitch; Steven Jacobson
Journal:  Curr Opin Virol       Date:  2014-10-17       Impact factor: 7.090

Review 5.  Human Herpesviruses 6A and 6B in Brain Diseases: Association versus Causation.

Authors:  Anthony L Komaroff; Philip E Pellett; Steven Jacobson
Journal:  Clin Microbiol Rev       Date:  2020-11-11       Impact factor: 26.132

6.  Predicting Hemagglutinin MHC-II Ligand Analogues in Anti-TNFα Biologics: Implications for Immunogenicity of Pharmaceutical Proteins.

Authors:  Benjamin J Andrick; Alexandra I Schwab; Brianna Cauley; Lauren A O'Donnell; Wilson S Meng
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

Review 7.  Beta and Gamma Human Herpesviruses: Agonistic and Antagonistic Interactions with the Host Immune System.

Authors:  Mario E Cruz-Muñoz; Ezequiel M Fuentes-Pananá
Journal:  Front Microbiol       Date:  2018-01-05       Impact factor: 5.640

8.  Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.

Authors:  Madlen Loebel; Maren Eckey; Franziska Sotzny; Elisabeth Hahn; Sandra Bauer; Patricia Grabowski; Johannes Zerweck; Pavlo Holenya; Leif G Hanitsch; Kirsten Wittke; Peter Borchmann; Jens-Ulrich Rüffer; Falk Hiepe; Klemens Ruprecht; Uta Behrends; Carola Meindl; Hans-Dieter Volk; Ulf Reimer; Carmen Scheibenbogen
Journal:  PLoS One       Date:  2017-06-12       Impact factor: 3.240

Review 9.  Possible role of human herpesvirus 6 as a trigger of autoimmune disease.

Authors:  Francesco Broccolo; Lisa Fusetti; Luca Ceccherini-Nelli
Journal:  ScientificWorldJournal       Date:  2013-10-24

Review 10.  Contributions of neurotropic human herpesviruses herpes simplex virus 1 and human herpesvirus 6 to neurodegenerative disease pathology.

Authors:  Jessica M Hogestyn; David J Mock; Margot Mayer-Proschel
Journal:  Neural Regen Res       Date:  2018-02       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.